| Pathway ID | Description | GeneNumber | ProteinNumber |
| 04010 |
MAPK signaling pathway |
163 |
186 |
| 04510 |
Focal adhesion |
158 |
219 |
| 04810 |
Regulation of actin cytoskeleton |
157 |
203 |
| 04060 |
Cytokine-cytokine receptor interaction |
131 |
143 |
| 01430 |
Cell Communication |
114 |
166 |
| 04020 |
Calcium signaling pathway |
110 |
131 |
| 04360 |
Axon guidance |
102 |
122 |
| 04910 |
Insulin signaling pathway |
97 |
110 |
| 04530 |
Tight junction |
96 |
111 |
| 04514 |
Cell adhesion molecules (CAMs) |
89 |
191 |
| 04310 |
Wnt signaling pathway |
89 |
103 |
| 00230 |
Purine metabolism |
81 |
92 |
| 04080 |
Neuroactive ligand-receptor interaction |
80 |
90 |
| 04670 |
Leukocyte transendothelial migration |
77 |
93 |
| 04512 |
ECM-receptor interaction |
76 |
125 |
| 04630 |
Jak-STAT signaling pathway |
76 |
81 |
| 04650 |
Natural killer cell mediated cytotoxicity |
74 |
141 |
| 04540 |
Gap junction |
73 |
79 |
| 04110 |
Cell cycle |
72 |
77 |
| 04120 |
Ubiquitin mediated proteolysis |
68 |
73 |
| 04912 |
GnRH signaling pathway |
65 |
73 |
| 04610 |
Complement and coagulation cascades |
65 |
104 |
| 04660 |
T cell receptor signaling pathway |
62 |
71 |
| 04916 |
Melanogenesis |
62 |
69 |
| 05222 |
Small cell lung cancer |
61 |
88 |
| 04640 |
Hematopoietic cell lineage |
61 |
78 |
| 04012 |
ErbB signaling pathway |
60 |
67 |
| 05215 |
Prostate cancer |
60 |
67 |
| 03010 |
Ribosome |
57 |
63 |
| 04520 |
Adherens junction |
57 |
75 |
| 04730 |
Long-term depression |
57 |
65 |
| 00190 |
Oxidative phosphorylation |
56 |
59 |
| 05214 |
Glioma |
55 |
62 |
| 00010 |
Glycolysis / Gluconeogenesis |
55 |
66 |
| 01030 |
Glycan structures - biosynthesis 1 |
55 |
60 |
| 04720 |
Long-term potentiation |
55 |
62 |
| 05210 |
Colorectal cancer |
55 |
57 |
| 04620 |
Toll-like receptor signaling pathway |
55 |
61 |
| 04210 |
Apoptosis |
54 |
61 |
| 04070 |
Phosphatidylinositol signaling system |
54 |
58 |
| 04350 |
TGF-beta signaling pathway |
54 |
59 |
| 05212 |
Pancreatic cancer |
53 |
56 |
| 00500 |
Starch and sucrose metabolism |
51 |
57 |
| 05220 |
Chronic myeloid leukemia |
50 |
52 |
| 04664 |
Fc epsilon RI signaling pathway |
48 |
49 |
| 03320 |
PPAR signaling pathway |
48 |
59 |
| 05211 |
Renal cell carcinoma |
48 |
50 |
| 05218 |
Melanoma |
46 |
51 |
| 04370 |
VEGF signaling pathway |
46 |
53 |
| 00240 |
Pyrimidine metabolism |
45 |
49 |
| 04920 |
Adipocytokine signaling pathway |
45 |
51 |
| 05130 |
Pathogenic Escherichia coli infection - EHEC |
43 |
51 |
| 05131 |
Pathogenic Escherichia coli infection - EPEC |
43 |
51 |
| 04612 |
Antigen processing and presentation |
42 |
111 |
| 04115 |
p53 signaling pathway |
42 |
46 |
| 05223 |
Non-small cell lung cancer |
41 |
41 |
| 04662 |
B cell receptor signaling pathway |
40 |
46 |
| 00350 |
Tyrosine metabolism |
40 |
44 |
| 05120 |
Epithelial cell signaling in Helicobacter pylori infection |
40 |
48 |
| 00071 |
Fatty acid metabolism |
39 |
41 |
| 00980 |
Metabolism of xenobiotics by cytochrome P450 |
39 |
39 |
| 05213 |
Endometrial cancer |
39 |
42 |
| 02010 |
ABC transporters - General |
37 |
41 |
| 00380 |
Tryptophan metabolism |
37 |
38 |
| 05221 |
Acute myeloid leukemia |
36 |
38 |
| 00620 |
Pyruvate metabolism |
35 |
41 |
| 05219 |
Bladder cancer |
34 |
36 |
| 00051 |
Fructose and mannose metabolism |
34 |
39 |
| 00280 |
Valine, leucine and isoleucine degradation |
34 |
37 |
| 00561 |
Glycerolipid metabolism |
34 |
42 |
| 00562 |
Inositol phosphate metabolism |
33 |
37 |
| 04930 |
Type II diabetes mellitus |
32 |
40 |
| 00564 |
Glycerophospholipid metabolism |
31 |
34 |
| 00640 |
Propanoate metabolism |
31 |
35 |
| 04150 |
mTOR signaling pathway |
30 |
32 |
| 00260 |
Glycine, serine and threonine metabolism |
30 |
33 |
| 00330 |
Arginine and proline metabolism |
29 |
31 |
| 05110 |
Cholera - Infection |
29 |
32 |
| 04940 |
Type I diabetes mellitus |
29 |
94 |
| 00310 |
Lysine degradation |
29 |
32 |
| 05320 |
Autoimmune thyroid disease |
28 |
93 |
| 00790 |
Folate biosynthesis |
27 |
28 |
| 00340 |
Histidine metabolism |
27 |
28 |
| 05330 |
Allograft rejection |
27 |
91 |
| 00120 |
Bile acid biosynthesis |
27 |
28 |
| 05217 |
Basal cell carcinoma |
27 |
27 |
| 00480 |
Glutathione metabolism |
27 |
28 |
| 00650 |
Butanoate metabolism |
27 |
27 |
| 05040 |
Huntington's disease |
26 |
27 |
| 00590 |
Arachidonic acid metabolism |
26 |
28 |
| 01510 |
Neurodegenerative Diseases |
26 |
35 |
| 00970 |
Aminoacyl-tRNA biosynthesis |
25 |
27 |
| 04330 |
Notch signaling pathway |
25 |
28 |
| 04340 |
Hedgehog signaling pathway |
25 |
25 |
| 03420 |
Nucleotide excision repair |
24 |
24 |
| 00251 |
Glutamate metabolism |
23 |
24 |
| 00052 |
Galactose metabolism |
23 |
29 |
| 00530 |
Aminosugars metabolism |
22 |
25 |
| 05332 |
Graft-versus-host disease |
22 |
86 |
| 01032 |
Glycan structures - degradation |
22 |
26 |
| 00220 |
Urea cycle and metabolism of amino groups |
22 |
24 |
| 00410 |
beta-Alanine metabolism |
21 |
21 |
| 00020 |
Citrate cycle (TCA cycle) |
21 |
23 |
| 00252 |
Alanine and aspartate metabolism |
21 |
21 |
| 05216 |
Thyroid cancer |
21 |
28 |
| 03050 |
Proteasome |
21 |
23 |
| 00510 |
N-Glycan biosynthesis |
21 |
24 |
| 04740 |
Olfactory transduction |
21 |
26 |
| 03030 |
DNA replication |
20 |
21 |
| 04742 |
Taste transduction |
20 |
26 |
| 00860 |
Porphyrin and chlorophyll metabolism |
19 |
19 |
| 00360 |
Phenylalanine metabolism |
19 |
19 |
| 04320 |
Dorso-ventral axis formation |
19 |
20 |
| 01031 |
Glycan structures - biosynthesis 2 |
19 |
21 |
| 04130 |
SNARE interactions in vesicular transport |
19 |
20 |
| 00030 |
Pentose phosphate pathway |
18 |
24 |
| 00450 |
Selenoamino acid metabolism |
18 |
19 |
| 00710 |
Carbon fixation |
18 |
22 |
| 03022 |
Basal transcription factors |
18 |
18 |
| 05010 |
Alzheimer's disease |
18 |
26 |
| 05310 |
Asthma |
17 |
18 |
| 00600 |
Sphingolipid metabolism |
17 |
22 |
| 00150 |
Androgen and estrogen metabolism |
17 |
17 |
| 00903 |
Limonene and pinene degradation |
17 |
17 |
| 03410 |
Base excision repair |
17 |
18 |
| 00591 |
Linoleic acid metabolism |
15 |
15 |
| 00632 |
Benzoate degradation via CoA ligation |
15 |
16 |
| 00512 |
O-Glycan biosynthesis |
15 |
16 |
| 03430 |
Mismatch repair |
15 |
17 |
| 00565 |
Ether lipid metabolism |
14 |
16 |
| 00100 |
Biosynthesis of steroids |
14 |
14 |
| 00624 |
1- and 2-Methylnaphthalene degradation |
13 |
13 |
| 00960 |
Alkaloid biosynthesis II |
13 |
14 |
| 00531 |
Glycosaminoglycan degradation |
13 |
15 |
| 00271 |
Methionine metabolism |
13 |
15 |
| 04614 |
Renin-angiotensin system |
13 |
15 |
| 00910 |
Nitrogen metabolism |
13 |
15 |
| 00641 |
3-Chloroacrylic acid degradation |
13 |
13 |
| 00760 |
Nicotinate and nicotinamide metabolism |
13 |
17 |
| 05020 |
Parkinson's disease |
13 |
19 |
| 05030 |
Amyotrophic lateral sclerosis (ALS) |
13 |
15 |
| 00361 |
gamma-Hexachlorocyclohexane degradation |
12 |
13 |
| 00630 |
Glyoxylate and dicarboxylate metabolism |
12 |
14 |
| 00272 |
Cysteine metabolism |
12 |
13 |
| 00511 |
N-Glycan degradation |
12 |
15 |
| 00930 |
Caprolactam degradation |
12 |
12 |
| 05050 |
Dentatorubropallidoluysian atrophy (DRPLA) |
11 |
16 |
| 05060 |
Prion disease |
11 |
12 |
| 00720 |
Reductive carboxylate cycle (CO2 fixation) |
11 |
11 |
| 00670 |
One carbon pool by folate |
10 |
13 |
| 00534 |
Heparan sulfate biosynthesis |
10 |
10 |
| 04950 |
Maturity onset diabetes of the young |
10 |
12 |
| 00532 |
Chondroitin sulfate biosynthesis |
9 |
9 |
| 00602 |
Glycosphingolipid biosynthesis - neo-lactoseries |
9 |
10 |
| 00062 |
Fatty acid elongation in mitochondria |
9 |
9 |
| 04140 |
Regulation of autophagy |
8 |
8 |
| 00521 |
Streptomycin biosynthesis |
8 |
11 |
| 00440 |
Aminophosphonate metabolism |
8 |
8 |
| 03020 |
RNA polymerase |
8 |
8 |
| 00626 |
Naphthalene and anthracene degradation |
8 |
8 |
| 00053 |
Ascorbate and aldarate metabolism |
8 |
8 |
| 01040 |
Biosynthesis of unsaturated fatty acids |
8 |
8 |
| 00770 |
Pantothenate and CoA biosynthesis |
8 |
8 |
| 00040 |
Pentose and glucuronate interconversions |
7 |
7 |
| 00533 |
Keratan sulfate biosynthesis |
7 |
8 |
| 04710 |
Circadian rhythm |
7 |
9 |
| 00363 |
Bisphenol A degradation |
7 |
7 |
| 00740 |
Riboflavin metabolism |
7 |
8 |
| 00290 |
Valine, leucine and isoleucine biosynthesis |
7 |
8 |
| 00603 |
Glycosphingolipid biosynthesis - globoseries |
7 |
7 |
| 00604 |
Glycosphingolipid biosynthesis - ganglioseries |
7 |
8 |
| 00563 |
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis |
7 |
8 |
| 00072 |
Synthesis and degradation of ketone bodies |
6 |
6 |
| 00680 |
Methane metabolism |
6 |
8 |
| 00460 |
Cyanoamino acid metabolism |
6 |
8 |
| 00592 |
alpha-Linolenic acid metabolism |
6 |
6 |
| 00140 |
C21-Steroid hormone metabolism |
6 |
6 |
| 00920 |
Sulfur metabolism |
6 |
6 |
| 00400 |
Phenylalanine, tyrosine and tryptophan biosynthesis |
6 |
6 |
| 00625 |
Tetrachloroethene degradation |
5 |
5 |
| 00900 |
Terpenoid biosynthesis |
5 |
5 |
| 03060 |
Protein export |
5 |
6 |
| 00750 |
Vitamin B6 metabolism |
5 |
7 |
| 00520 |
Nucleotide sugars metabolism |
4 |
5 |
| 00950 |
Alkaloid biosynthesis I |
4 |
4 |
| 00430 |
Taurine and hypotaurine metabolism |
4 |
4 |
| 00061 |
Fatty acid biosynthesis |
4 |
5 |
| 00232 |
Caffeine metabolism |
4 |
4 |
| 00940 |
Phenylpropanoid biosynthesis |
3 |
3 |
| 00791 |
Atrazine degradation |
3 |
3 |
| 00830 |
Retinol metabolism |
3 |
4 |
| 00130 |
Ubiquinone biosynthesis |
3 |
3 |
| 00730 |
Thiamine metabolism |
3 |
3 |
| 00550 |
Peptidoglycan biosynthesis |
3 |
4 |
| 00281 |
Geraniol degradation |
3 |
3 |
| 00643 |
Styrene degradation |
3 |
3 |
| 00401 |
Novobiocin biosynthesis |
3 |
3 |
| 00031 |
Inositol metabolism |
2 |
3 |
| 00471 |
D-Glutamine and D-glutamate metabolism |
2 |
2 |
| 00601 |
Glycosphingolipid biosynthesis - lactoseries |
2 |
3 |
| 00300 |
Lysine biosynthesis |
2 |
2 |
| 00660 |
C5-Branched dibasic acid metabolism |
1 |
1 |
| 00627 |
1,4-Dichlorobenzene degradation |
1 |
1 |
| 00902 |
Monoterpenoid biosynthesis |
1 |
1 |
| 00364 |
Fluorobenzoate degradation |
1 |
1 |
| 00780 |
Biotin metabolism |
1 |
2 |